These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20838729)

  • 1. High-risk patients benefit most from nifedipine GITS-telmisartan combination.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(4):235. PubMed ID: 20838729
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine and telmisartan for the treatment of hypertension: the TALENT study.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1499-503. PubMed ID: 22103868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
    Du H; Fan J; Ling Z; Woo K; Su L; Chen S; Liu Z; Lan X; Zhou B; Xu Y; Chen W; Xiao P; Yin Y
    Hypertension; 2013 Apr; 61(4):786-92. PubMed ID: 23438932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
    Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
    J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan/amlodipine: single-pill combination in hypertension.
    Moen MD
    Am J Cardiovasc Drugs; 2010; 10(6):401-12. PubMed ID: 21090832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
    Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
    Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
    Karas M; Lacourcière Y; LeBlanc AR; Nadeau R; Dubé B; Florescu M; Lamarre-Cliche M; Poirier L; Larochelle P; de Champlain J
    J Hypertens; 2005 Jun; 23(6):1251-60. PubMed ID: 15894902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
    Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
    Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
    Dupuis F; Vincent JM; Limiñana P; Chillon JM; Capdeville-Atkinson C; Atkinson J
    J Hypertens; 2010 Jul; 28(7):1566-73. PubMed ID: 20589978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
    Guthrie RM
    Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
    Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
    Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension.
    Wells TG; Portman R; Norman P; Haertter S; Davidai G; Fei Wang
    Clin Pediatr (Phila); 2010 Oct; 49(10):938-46. PubMed ID: 20724342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].
    Chazova IE
    Ter Arkh; 2003; 75(6):89-91. PubMed ID: 12920969
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
    Kario K; Hoshide S; Uchiyama K; Yoshida T; Okazaki O; Noshiro T; Aoki H; Mizuno H; Matsumoto Y
    J Clin Hypertens (Greenwich); 2016 Oct; 18(10):1036-1044. PubMed ID: 26989846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
    Segura J; Ruilope LM
    Vasc Health Risk Manag; 2013; 9():521-8. PubMed ID: 24082785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
    Nalbantgil I; Nalbantgil S; Ozerkan F; Yilmaz H; Gürgün C; Zoghi M; Aytimur M; Onder R
    Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of treatment with telmisartan-amlodipine in hypertensive patients.
    Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
    J Clin Hypertens (Greenwich); 2009 Apr; 11(4):207-13. PubMed ID: 19614805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto S; Matsumoto K
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):206-13. PubMed ID: 20197015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of telmisartan 80 mg once daily on 24-h blood pressure profile in patients with mild-to-moderate hypertension failing to respond to prior antihypertensive therapy.
    Parra Carrillo JZ; Fernández M; Barrera M; Bahena J; Estrella M; Olivares Ruiz R; Lepe L; Arriaga R; Bonilla C; Fonseca S; Miranda S; Segovia C; García Luna Viesca MD
    Int J Clin Pract Suppl; 2004 Dec; (145):9-15. PubMed ID: 15617453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study.
    Alcocer L; Fernandez-Bonetti P; Campos E; Dominguez-Henkel R; de la Fuente JJ; Segovia-Ayala C
    Int J Clin Pract Suppl; 2004 Dec; (145):23-8. PubMed ID: 15617455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.